Document Type : Case Series
Authors
1 Department of Emergency Medicine, RajaRajeswari Medical College and Hospital Bangalore, Karnataka – 560074, India
2 Department of Emergency Medicine, Kanachur Institute of Medical Sciences, Mangalore-575018, India
Abstract
Introduction: Eucalyptus oil is a volatile hydrocarbon produced by the distillation process from Eucalyptus leaves. The oil can be absorbed through dermal exposure, inhalation, and ingestion. The symptoms of poisoning may include nausea, vomiting, diarrhea, dizziness, difficulty breathing, and coma, and seizures and kidney injuries have been reported as some of the complications. The poisoning-related complications are more common in children than adults.
Case presentation: In this study, we included six adult patients who presented to the emergency department and developed rhabdomyolysis as a complication during their hospital stay. All the cases had a history of eucalyptus oil intoxication. The mean age of the cohort, comprising two males and four females, was 25±4 years. The average amount of eucalyptus oil exposure was 14±7 mL. Two patients underwent dialysis, and one required mechanical ventilatory support. All six cases were discharged from the hospital after complete recovery.
Discussion: Rhabdomyolysis is a rare complication of eucalyptus oil poisoning. The study participants initially presented a wide spectrum of complaints, such as asymptomatic (n=1), convulsions (n=3), pain in the abdomen (n=1), and vomiting(n=1). Surprisingly, patients asymptomatic at presentation also developed rhabdomyolysis. The typical treatment for eucalyptus oil poisoning involves supportive care and close monitoring of vital signs. Patients who developed eucalyptus oil-associated rhabdomyolysis were treated with intravenous fluid, diuretics, and corticosteroids.
Conclusion: Rhabdomyolysis is a rare complication following ingestion of eucalyptus oil. Awareness of this complication is vital for early diagnosis and proper treatment, especially in regions where eucalyptus oil is readily available and used.
Keywords
Main Subjects
- Hu Z, Feng R, Xiang F, Song X, Yin Z, Zhang C, et al. Acute and subchronic toxicity as well as evaluation of safety pharmacology of eucalyptus oil-water emulsions. Int J Clin Exp Me. 2014 Dec 15;7(12):4835-45.
- Ali B, Al-Wabel NA, Shams S, Ahamad A, Khan SA, Anwar F. Essential oils used in aromatherapy: A systemic review. Asian Pac J Trop Biomed. 2015 Aug 1;5(8):601–11.
- Dudipala SC, Mandapuram P, Ch LK. Eucalyptus Oil-Induced Seizures in Children: Case Reports and Review of the Literature. J Neurosci Rural Pract. 2021 Jan;12(1):112–5.
- Ittyachen AM, George GR, Radhakrishnan M, Joy Y. Eucalyptus oil poisoning: two case reports. J Med Case Reports. 2019 Nov 4;13(1):326.
- Gnanasekaran K, Jayakumar D. Multisystem Organ Failure in A Patient with Eucalyptus Oil Poisoning – A Case Report. Indian J Sci Technol. 2023 Nov 17;16(43):3959–61.
- Mathew T, K John S, Kamath V, Kumar R S, Jadav R, Swamy S, et al. Essential oil related seizures (EORS): A multi-center prospective study on essential oils and seizures in adults. Epilepsy Res. 2021 Jul;173:106626.
- Wojtunik-Kulesza KA. Toxicity of Selected Monoterpenes and Essential Oils Rich in These Compounds. Molecules. 2022 Jan;27(5):1716.
- Wang L, Hong S, Huang H, Yang M. Rhabdomyolysis following status epilepticus with hyperuricemia: A case report and literature review. Medicine (Baltimore). 2018 Jun 1;97:e11281.
- Mathew T, John SK, Kamath V, Kumar R S, Jadav R, Shaji A, et al. Essential oil–related status epilepticus: A small case series study. J Am Coll Emerg Physicians Open. 2020 Jun 25;1(5):918–21.
- Becker LC, Akinsulie A, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, et al. Safety Assessment of Eucalyptus globulus (Eucalyptus)-Derived Ingredients as Used in Cosmetics. Int J Toxicol. 2023 Jun 1;42(1_suppl):57S-92S.
- Mathew T, Kamath V, Kumar RS, Srinivas M, Hareesh P, Jadav R, et al. Eucalyptus oil inhalation–induced seizure: A novel, underrecognized, preventable cause of acute symptomatic seizure. Epilepsia Open. 2017 Jul 4;2(3):350–4.
- Shanmugam S, Sethuraman R, Chakravarthy T, Krishnan G, Kavitha B, Shakila J, et al. Rhabdomyolysis and Pigment Nephropathy – An Uncommon Manifestation of Eucalyptus Oil Consumption. Indian J Nephrol. 2024;34(5):516–7.
- Yu CH, Huang LC, Su YJ. Poisoning-Induced Acute Kidney Injury: A Review. Medicina (Mex). 2024 Aug;60(8):1302.
- Kashyap R. Exploring the Molecular Mechanisms and Therapeutic Potentials of Essential Oils: A Systems Biology Approach. Future Integr Med. 2024 Jun 28;3(2):116–31.
- Brand MD, Orr AL, Perevoshchikova IV, Quinlan CL. The role of mitochondrial function and cellular bioenergetics in ageing and disease. Br J Dermatol. 2013 Jul;169(0 2):1–8.
- Döll-Boscardin PM, Sartoratto A, Sales Maia BHL de N, Padilha de Paula J, Nakashima T, Farago PV, et al. In Vitro Cytotoxic Potential of Essential Oils of Eucalyptus benthamii and Its Related Terpenes on Tumor Cell Lines. Evid Based Complement Alternat Med. 2012;2012(1):342652.
- Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians. Crit Care. 2005;9(2):158–69.
- Patel SK, Padala SA, Mohammed A, Kapoor R. Role of Corticosteroids in Rhabdomyolysis. Integr J Nephro Urol Stud, 2019:1(1): 1–4.
- Rogliano PF, Voicu S, Labat L, Deye N, Malissin I, Laplanche JL, et al. Acute Poisoning with Rhabdomyolysis in the Intensive Care Unit: Risk Factors for Acute Kidney Injury and Renal Replacement Therapy Requirement. Toxics. 2020 Dec;8(4):79.